Patient advocate Jimi Olaghere shares his lived expertise with Sickle Cell Disease (SCD) and what it was like to participate in a clinical trial receiving CASGEVY, an autologous, one-time, CRISPR/Cas9-edited cellular gene therapy.
Lead Webcast
PODD 2025 Patient Keynote: A Sickle Cell Patient’s Lived Experience with a Clinical Trial
Featured Videos & Webcasts
